LAG3 and neoplasm: Interestingly, a significant correlation was detected between the tumor burden and the expansion of TCRED-LAG-3KO T cells, but not with TCRED-IRCOMP T cells, suggesting a dose-dependent tumor killing in the absence of LAG-3 (Supplementary Figure 7D).